|
Last Updated: Nov 18, 2006 - 12:32:53 PM |
Latest Research
:
Surgery
:
CTVS
Older blood associated with worse outcomes after repeat heart surgery
Older stored blood transfused into patients undergoing repeat heart surgery is associated with a significant increased risk of death, both during a patient's hospital stay and over the longer term following discharge, according to a new analysis by researchers from Duke University Medical Center and Columbia University.
Jun 22, 2006 - 11:34:00 PM
Latest Research
:
Surgery
:
CTVS
Preventing spinal cord injury during aortic surgery
Surgery to repair aortic aneurysms often comes with a high price: neurological deficits, but new research points to a possible defense against spinal cord injury during aortic surgery. The paper by Roseborough et al., "The mitochondrial K-ATP channel opener, diazoxide, prevents ischemia-reperfusion injury in the rabbit spinal cord," appears in the May issue of The American Journal of Pathology.
Jun 22, 2006 - 5:13:00 PM
Latest Research
:
Surgery
:
CTVS
Drug-eluding stents seems to be a viable alternative to CABG for patients with severe coronary artery disease
Severe stenosis (blockage) to the left main coronary artery - a condition commonly called a "widow-maker"- can result in sudden death. For nearly 30 years, the gold standard for treatment has been coronary artery bypass surgery (CABG).
Feb 28, 2006 - 5:50:00 PM
Latest Research
:
Surgery
:
CTVS
Women's increased risk of mortality after coronary artery bypass surgery is due to infections
For years, experts have puzzled over the fact that women who have heart bypass surgery are far more likely than their male counterparts to die within days or weeks of their operation. This gender gap means many "extra" female deaths among the 270,000 Americans who have bypass surgery each year.
Feb 28, 2006 - 5:27:00 PM
Latest Research
:
Surgery
:
CTVS
Different Drug-Releasing Coronary Stents Show Similar Effectiveness
Use of coronary stents that release the drugs sirolimus or paclitaxel produced similar results in patients with new coronary artery lesions, according to a study in the February 22 issue of JAMA.
Feb 23, 2006 - 3:01:00 PM
Latest Research
:
Surgery
:
CTVS
A novel collapsible heart valve can revolutionize the present invasive open heart surgery in children
Children with congenital heart defects may soon have an alternative to invasive open heart surgery that will mean less time in the hospital, a quicker recovery and no need to break open the breastbone, thanks to a new collaboration between researchers at the UCLA Henry Samueli School of Engineering and Applied Science and pediatric cardiologists at Mattel Children�s Hospital at UCLA.
Feb 14, 2006 - 5:35:00 PM
Latest Research
:
Surgery
:
CTVS
Lung-volume reduction surgery strongly recommended for end-stage emphysema patients
Tens of thousands of Americans living with emphysema would benefit from a surgical procedure that removes part of the lung, according to national research presented yesterday by a Saint Louis University cardiothoracic surgeon.
Jan 30, 2006 - 8:23:00 PM
Latest Research
:
Surgery
:
CTVS
Causes of cognitive loss following coronary artery bypass surgery identified
Minimizing trauma to the body's largest artery � the aorta � during heart bypass surgery can significantly reduce cognitive loss that often follows the operation, a team from Wake Forest University School of Medicine reported today (Jan. 21) in the Journal of Thoracic and Cardiovascular Surgery.
Jan 22, 2006 - 2:54:00 PM
Latest Research
:
Surgery
:
CTVS
Minimizing aortic manipulations can significantly reduce the incidence of cognitive deficits in CABG patients
Minimizing trauma to the body's largest artery � the aorta � during heart bypass surgery can significantly reduce cognitive loss that often follows the operation, a team from Wake Forest University School of Medicine reported today (Jan. 21) in the Journal of Thoracic and Cardiovascular Surgery.
Jan 21, 2006 - 6:08:00 PM
Latest Research
:
Surgery
:
CTVS
Drug-eluting stents may cause allergic reactions
Drug-eluting stents have greatly reduced the risk of repeat blockage of heart arteries, but researchers from Northwestern Memorial Hospital have found that in some patients, the stents can cause allergic reactions that can have serious consequences. They stress that physicians and their patients should be aware of this potential and know the symptoms.
Dec 20, 2005 - 12:10:00 AM
Latest Research
:
Surgery
:
CTVS
Minimally invasive surgery more patient friendly for the elderly with lung cancer
Like their younger counterparts, some elderly patients who have early stage non-small cell lung cancer can benefit from a minimally invasive surgical procedure to remove part or all of a lung, according to a study conducted by thoracic surgeons at Cedars-Sinai Medical Center and described in The American Surgeon, the journal of the Southeastern Surgical Congress and the Southern California Chapter of the American College of Surgeons.
Dec 7, 2005 - 3:50:00 AM
Latest Research
:
Surgery
:
CTVS
Intact fat tissue around internal mammary artery during CABG surgery provides better blood flow
A team of McMaster researchers has discovered that fat tissue surrounding thoracic arteries may be beneficial in patients undergoing coronary bypass surgery.
Dec 6, 2005 - 5:49:00 AM
Latest Research
:
Surgery
:
CTVS
MC-1 Demonstrates Statistically Significant Reduction in Post-operative Mortality after Bypass Surgery
Medicure Inc. (TSX:MPH)(AMEX:MCU), a cardiovascular drug discovery and development company is pleased to report positive results with its FDA Fast Tracked cardioprotective product, MC-1, in the Phase II MEND-CABG study. The MEND-CABG study is a double blind, parallel group, randomized, placebo-controlled study in 901 patients who underwent coronary artery bypass graft (CABG) surgery. Based on the positive results, the Company plans to move forward with a pivotal Phase III clinical development program for MC-1.
Dec 6, 2005 - 3:29:00 AM
Latest Research
:
Surgery
:
CTVS
Heparin antibodies increase mortality in heart surgery patients
New research suggests that patients who develop antibodies to the anti-clotting drug heparin nearly double their risk of death or serious complication after heart surgery.
Dec 5, 2005 - 6:12:00 AM
Latest Research
:
Surgery
:
CTVS
Adult Stem Cells via Endoscopic Injections Can be Used to Treat Heart Failure
Two leading cardiac surgeons in adult stem cell therapy for heart disease presented the use of adult stem cells via endoscopic injection to treat heart failure patients during their talks at the International Society for Heart and Lung Transplantation Fall Education Meeting: �Synergy: Mechanical and Biological Cardiac Support - Recovery, Replacement, and Repair with Cellular Therapy.�
Nov 21, 2005 - 12:05:00 AM
Latest Research
:
Surgery
:
CTVS
Robotic CABG with Stenting Speeds up Recovery
Combining robotically assisted coronary artery bypass surgery (CABG) with stented angioplasty shows promise for treating extensive coronary artery disease, researchers reported at the American Heart Association Scientific Sessions 2005.
Nov 20, 2005 - 11:52:00 PM
Latest Research
:
Surgery
:
CTVS
Patients with Peripheral Artery Disease are Under Treated
Despite the fact that clogged arteries in the legs usually mean clogged arteries near the heart, doctors often fail to give heart-protecting drugs to people with severe leg blood vessel blockages, a new University of Michigan-led study finds.
Nov 20, 2005 - 11:33:00 PM
Latest Research
:
Surgery
:
CTVS
Pexelizumab being investigated to reduce perioperative mortality in patients undergoing CABG-CPB surgery
Alexion Pharmaceuticals, Inc. and Procter & Gamble Pharmaceuticals (P&GP), a division of The Procter & Gamble Company, announced today the completion of enrollment for the pivotal Phase III PRIMO-CABG2 efficacy trial of pexelizumab. This agent is being investigated for reducing mortality and myocardial infarction (heart attack) following coronary artery bypass graft (CABG) surgery.
Aug 11, 2005 - 1:05:00 AM
Latest Research
:
Surgery
:
CTVS
OLYMPIA Registry to Become Largest Drug- eluting Stent Registry
Scientific Corporation ("BSC") today announced that it has completed enrollment in the transitional phase of the world's largest drug-eluting stent registry. The OLYMPIA registry plans to enroll more than 30,000 patients at more than 600 centers in the United States, Europe and other international locations.
Jun 21, 2005 - 10:40:00 AM
Latest Research
:
Surgery
:
CTVS
Bypass surgery free of long-term Brain effects
A broad retrospective review of the effects of coronary artery bypass grafting (CABG) on memory and other brain functions concludes that, while there may be transient short-term effects, the procedure itself probably does not cause late or permanent neurological effects.
Apr 25, 2005 - 7:38:00 PM
Latest Research
:
Surgery
:
CTVS
Results From Edifoligide (E2F Decoy) Phase 3 Trial for Coronary Artery Bypass Graft Failure
Corgentech Inc. (Nasdaq: CGTK), and Bristol-Myers Squibb Company (NYSE: BMY) today announced top-line results from PREVENT IV, a Phase 3 clinical trial evaluating the use of edifoligide (E2F Decoy), an investigational product, to prevent vein graft failure following coronary artery bypass graft (CABG) surgery.
Mar 31, 2005 - 9:26:00 PM
<< prev
next >>
|
